Media Releases

Date Title Download
Date23.12.2016 TitleVifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance Download Vifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance
Date23.12.2016 TitleVifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance to include CCX140 to treat renal diseases Download Vifor Pharma and ChemoCentryx announce expansion of Kidney Health Alliance to include CCX140 to treat renal diseases
Date09.12.2016 TitleSwisscom Health to take over Galenica practice information system Download Swisscom Health to take over Galenica practice information system
Date07.12.2016 TitleEFFECT-HF demonstrates a significantly beneficial effect of Ferinject® on exercise capacity among patients with chronic heart failure and iron deficiency – confirms findings of previous studies Download EFFECT-HF demonstrates a significantly beneficial effect of Ferinject® on exercise capacity among patients with chronic heart failure and iron deficiency – confirms findings of previous studies
Date28.11.2016 TitleFDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-Drug Interactions Download FDA Approves Supplemental New Drug Application for Veltassa® Removing Boxed Warning Regarding Drug-Drug Interactions
Date24.11.2016 TitleVifor Pharma leads initiatives to raise awareness of Iron Deficiency – 2nd Global Iron Deficiency Day on November 26, 2016 Download Vifor Pharma leads initiatives to raise awareness of Iron Deficiency – 2nd Global Iron Deficiency Day on November 26, 2016
Date25.10.2016 TitleSwissmedic approves ALOXI® for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Children in Switzerland Download Swissmedic approves ALOXI® for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Children in Switzerland
Date06.10.2016 TitleNew management at Vifor Pharma and new Galenica Group CFO designated Download New management at Vifor Pharma and new Galenica Group CFO designated
Date02.09.2016 TitleGalenica completes acquisition of Relypsa Download Galenica completes acquisition of Relypsa
Date01.09.2016 TitleGalenica announces Expiration of Cash Tender Offer for Relypsa Download Galenica announces Expiration of Cash Tender Offer for Relypsa
Date09.08.2016 TitleGalenica Group half year results 2016 Download Galenica Group half year results 2016
Date04.08.2016 TitleGalenica commences Tender Offer for Relypsa Download Galenica commences Tender Offer for Relypsa
Date21.07.2016 TitleGalenica to acquire Relypsa to strengthen its Business unit Vifor Pharma Download Galenica to acquire Relypsa to strengthen its Business unit Vifor Pharma
Date24.05.2016 TitleVifor Pharma to license commercialisation rights to Pfizer’s proposed biosimilar, Retacrit™, in the field of nephrology in the US Download Vifor Pharma to license commercialisation rights to Pfizer’s proposed biosimilar, Retacrit™, in the field of nephrology in the US
Date24.05.2016 TitleVifor Pharma strengthens company management – division of Galenica to take place once the new management is in place Download Vifor Pharma strengthens company management – division of Galenica to take place once the new management is in place
Date23.05.2016 TitleESC guidelines strongly recommend Ferinject® as a treatment for iron deficiency in systolic heart failure patients Download ESC guidelines strongly recommend Ferinject® as a treatment for iron deficiency in systolic heart failure patients
Date20.05.2016 TitleThe Galenica Group plans to take over SD wholesaler Pharmapool Download The Galenica Group plans to take over SD wholesaler Pharmapool
Date11.05.2016 TitleChange to the shareholder structure of the Galenica Group Download Change to the shareholder structure of the Galenica Group
Date10.05.2016 TitleVifor Pharma licenses marketing rights to CCX168 in certain territories Download Vifor Pharma licenses marketing rights to CCX168 in certain territories
Date10.05.2016 TitleVifor Pharma appoints Colin Bond as Chief Financial Officer Download Vifor Pharma appoints Colin Bond as Chief Financial Officer
Date09.05.2016 TitleVifor Fresenius Medical Care Renal Pharma acquires marketing rights to RAYALDEE® Download Vifor Fresenius Medical Care Renal Pharma acquires marketing rights to RAYALDEE®
Date28.04.2016 Title2016 Annual General Meeting of Galenica Ltd. Download 2016 Annual General Meeting of Galenica Ltd.
Date25.04.2016 TitlePatiromer submitted to EMA to seek approval in the EU Download Patiromer submitted to EMA to seek approval in the EU
Date15.03.2016 TitleResults of the Galenica Group 2015 Download Results of the Galenica Group 2015
Date21.01.2016 Title2015 sales of the Galenica Group Download 2015 sales of the Galenica Group